Control of modifiable risk factors in ischemic stroke outpatients by pharmacist intervention: an equal allocation stratified randomized study

Abstract

Pharmacist intervention was associated with improved BP control but not with the other MRF. Earlier initiation and longer duration of intervention may improve the outcome further, and whether targeting of high-risk subjects may be particularly rewarding is worthy of investigation.

The role of clinical pharmacist on lipid control in dyslipidemic patients in North of Jordan

“…These results are similar to our study also; however greater goal attainment was seen in our study and this can be explained by the fact that pharmacists in the previous study did not give dietary advice, while in our study patients were thoroughly educated about diet and brochures listing cholesterol and fat content of different types of food were distributed [16]. Several international studies also had similar findings to our study [9,10,17]; In Taiwan, a prospective randomized controlled study was conducted to evaluate the adequacy of management of modifiable risk factors including lipid profile, and the value of pharmacist interventions, in a group of ischemic stroke outpatients. By the end of the study, the percent of patients with adequate lipid control was higher in the intervention group who were followed by a pharmacist and physician compared to patients receiving standard medical care (40% vs. 27%; P = 0.16).…”

“…By the end of the study, the percent of patients with adequate lipid control was higher in the intervention group who were followed by a pharmacist and physician compared to patients receiving standard medical care (40% vs. 27%; P = 0.16). In the previous study pharmacist intervention was limited to a monthly 1-h education program regarding drug effects, life style modification, treatment goals and other relevant information; however the pharmacist did not provide physicians with individualized recommendations regarding dyslipidemia management [17]. In Lee et al and Phumipamorn et al [9,10] pharmacist interventions were merely patient education and pharmacists did not interfere with physicians' therapeutic decisions, unlike our study, in which pharmacist services included both patient education and provision of recommendations to physicians including agent choice, dose, dosage adjustment, management of side effects and others relevant information.…”

A pilot study to assess the practicality, acceptability and feasibility of a randomised controlled trial to evaluate the impact of a pharmacist complex intervention on patients with stroke in their own homes

“…The intervention consisted of 6×1 hour face-to-face counselling sessions in 160 patients for 6 months in a hospital outpatient clinic. The design and reporting of this study limits its interpretation 10. Pharmacist telephone interventions in patients with stroke have been shown to help reach secondary stroke prevention goals 11.…”

ASHP Guidelines on Pharmacist Involvement in HIV Care

“…The literature demonstrates that interdisciplinary teams including active pharmacist intervention improve management of ischemic stroke risk factors. 142 Pharmacists should encourage intensive management of these risk factors and other lifestyle modifications, such as smoking cessation, exercise regimens, and weight management programs.…”